CDER-2023-118707-Delivery of Human Blood Donor for Bioassay Development.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- June 7, 2023
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Place of performance
- Silver Spring, MD, 20903
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- FDA-RFQ-CDER-2023-118707
- Notice ID
- fbad75b07fa14203b53043094c0f9ab1
Description
The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure CDER-2023-118707 Delivery of Human Blood Donor for Bioassay Development. Per Attached RFQ
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-RFQ-CDER-2023-118707- Combined Synopsis
- 2×Combined SynopsisCurrentJun 7, 2023
CDER-2023-118707-Delivery of Human Blood Donor for Bioassay Development.
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDA-RFQ-CDER-2023-118707
Archive Date
Jul 10, 2023
Office Address
Beltsville, MD, 20705